Scientists have developed polypeptide-based materials
that act as effective vectors for delivering gene therapies. The
first-of-its-kind platform enables the vectors to be adapted to
suit the specific gene therapy cargo.
New adaptable nanoparticle platform enables enhanced
delivery of gene therapies

